erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hoarseness D006685 2 associated lipids
Occupational Injuries D060051 1 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Cheftel E et al. [Toxic food infection caused by Shigella flexneri in a military unit]. 1997 Sep-Oct Sante pmid:9480034
Saito A [Emerging infectious diseases--Legionella pneumophila infections]. 1997 Nippon Naika Gakkai Zasshi pmid:9480307
Kurmanova KB et al. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas]. 1997 Antibiot. Khimioter. pmid:9480650
Stout JE et al. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells. 1998 Diagn. Microbiol. Infect. Dis. pmid:9488830
Anderson KL et al. Conjugal transfer of transposon Tn1545 into the cellulolytic bacterium Eubacterium cellulosolvens. 1998 Lett. Appl. Microbiol. pmid:9489031
Hoppe JE [Pertussis: current aspects of diagnosis, therapy and prevention]. 1998 Ther Umsch pmid:9492614
Pereda A et al. The loading domain of the erythromycin polyketide synthase is not essential for erythromycin biosynthesis in Saccharopolyspora erythraea. 1998 Microbiology (Reading, Engl.) pmid:9493390
Kondoh K and Hashiba M [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa]. 1998 Nippon Jibiinkoka Gakkai Kaiho pmid:9493436
Wong PW et al. Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy. 1998 South. Med. J. pmid:9496876
Kataja J et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. 1998 J. Infect. Dis. pmid:9498465
Woodward A and Sillin LF Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer. 1998 Br J Surg pmid:9501836
Wong SL et al. The effect of erythromycin on the CYP3A component of sertindole clearance in healthy volunteers. 1997 J Clin Pharmacol pmid:9505999
Kamoun A et al. [Pneumococcal infections: penicillin resistance and therapeutic implications]. 1995 Tunis Med pmid:9506153
Rivera P et al. [Collagenous colitis: presentation of 12 cases]. 1997 Gastroenterol Hepatol pmid:9508483
Tsiaoussis I et al. Gallbladder fasting volume is reduced and gallbladder postprandial emptying is enhanced by intravenous erythromycin. 1998 Dig. Dis. Sci. pmid:9508522
Chen JD et al. Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis. 1998 Dig. Dis. Sci. pmid:9508540
Hay PE Therapy of bacterial vaginosis. 1998 J. Antimicrob. Chemother. pmid:9511031
Manninen R et al. Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Finnish Study Group for Antimicrobial Resistance. 1998 J. Antimicrob. Chemother. pmid:9511033
Williams JD et al. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. 1997 J. Antimicrob. Chemother. pmid:9511061
Jorgensen JH and McElmeel ML Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae. 1997 J. Antimicrob. Chemother. pmid:9511067
Perez-Trallero E et al. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. 1998 Eur. J. Clin. Microbiol. Infect. Dis. pmid:9512178
Noguchi N and Katayama J Expression in Pseudomonas aeruginosa of an erythromycin-resistance determinant that encodes the mphA gene for macrolide 2'-phosphotransferase I from Escherichia coli. 1998 Biol. Pharm. Bull. pmid:9514620
Wynn RL Serious erythromycin interactions caused by inhibition of drug metabolism in the liver. 1996 Nov-Dec Gen Dent pmid:9515389
Lu G et al. Effect of motilin and erythromycin on calcium-activated potassium channels in rabbit colonic myocytes. 1998 Gastroenterology pmid:9516395
Sato K et al. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. 1998 Am. J. Respir. Crit. Care Med. pmid:9517602
Pankuch GA et al. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. 1998 Antimicrob. Agents Chemother. pmid:9517943
Lalloo AK et al. Development of a capillary electrophoretic method for the separation of the macrolide antibiotics, erythromycin, josamycin and oleandomycin. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9518167
Lalloo AK and Kanfer I Determination of erythromycin and related substances by capillary electrophoresis. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9518168
Service RF Hijacking a cell's chemical paths to make new antibiotics. 1997 Science pmid:9518361
Esposito S et al. Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. 1998 Jan-Feb Clin Ther pmid:9522105
Lester GD et al. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. 1998 Am. J. Vet. Res. pmid:9522953
Liu PC et al. Susceptibility of different isolates of Vibrio harveyi to antibiotics. 1997 Microbios pmid:9523424
Janicka G et al. [Resistance to antibiotics of Streptococcus pneumoniae strains]. 1997 Pol. Merkur. Lekarski pmid:9523479
Roberts GJ et al. Bacteremia of dental origin and antimicrobial sensitivity following oral surgical procedures in children. 1998 Jan-Feb Pediatr Dent pmid:9524970
Ponomareva TR and Smolianskaia AZ [Prevalence of markers characteristic for penicillinase plasmids in clinical strains of straphylococci]. 1976 Antibiotiki pmid:952503
Seppälä H et al. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. 1998 Antimicrob. Agents Chemother. pmid:9527769
den Hollander JG et al. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. 1998 Antimicrob. Agents Chemother. pmid:9527789
Constantine PA Antibiotic therapy and serum digoxin toxicity. 1998 Am Fam Physician pmid:9531908
Salmon SA et al. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. 1998 J. Dairy Sci. pmid:9532511
Molinari JA Multifactorial aspects of legionellosis. 1997 Compend Contin Educ Dent pmid:9533308
Doucet-Populaire F et al. Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis. 1998 J. Antimicrob. Chemother. pmid:9533459
Nasher MA and Hay RJ Synergy of antibiotics against Streptomyces somaliensis isolates in vitro. 1998 J. Antimicrob. Chemother. pmid:9533473
Stout JE et al. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. 1998 J. Antimicrob. Chemother. pmid:9533475
Choi MG et al. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. 1998 J. Pharmacol. Exp. Ther. pmid:9535992
Lyon AJ et al. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. 1998 Arch. Dis. Child. Fetal Neonatal Ed. pmid:9536833
Jacobsen JR et al. Spontaneous priming of a downstream module in 6-deoxyerythronolide B synthase leads to polyketide biosynthesis. 1998 Biochemistry pmid:9538011
Williamson KM et al. Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. 1998 Clin. Pharmacol. Ther. pmid:9542475
Norcia LJ et al. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. 1998 J. Antibiot. pmid:9544934
Thomas AR et al. Prolongation of the QT interval related to cisapride-diltiazem interaction. 1998 Mar-Apr Pharmacotherapy pmid:9545159
Fitzgerald NB et al. Sonication-dependent electroporation of the erythromycin-producing bacterium Saccharopolyspora erythraea. 1998 Appl. Environ. Microbiol. pmid:9546194
Li YX et al. Sensitive determination of erythromycin in human plasma by LC-MS/MS. 1998 J Pharm Biomed Anal pmid:9547699
Bertho G et al. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations. 1998 Bioorg. Med. Chem. pmid:9547944
Tanaka E and Breimer DD In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. 1997 J Clin Pharm Ther pmid:9548204
Sachdeo RC et al. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy. 1998 J Clin Pharmacol pmid:9549651
Chakrabarti MK et al. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. 1998 Mar-Apr Chemotherapy pmid:9551241
Mück W et al. Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. 1998 Eur. J. Clin. Pharmacol. pmid:9551706
Mortensen JE et al. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. 1998 Diagn. Microbiol. Infect. Dis. pmid:9554176
Schwarz MI A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. 1998 Chest pmid:9554657
Lilley LL and Guanci R Drug interaction triggers weakness. 1998 Am J Nurs pmid:9556673
Konturek JW and Domschke W [Gastroparesis--physiopathology, diagnosis and the latest therapy]. 1998 Dtsch. Med. Wochenschr. pmid:9556697
Shah F Erythromycin. 1998 Pediatr Rev pmid:9557068
Ross JI et al. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. 1998 Dermatology (Basel) pmid:9557230
Cleary RK et al. Metronidazole may inhibit intestinal colonization with Clostridium difficile. 1998 Dis. Colon Rectum pmid:9559631
Rutman A et al. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. 1998 Antimicrob. Agents Chemother. pmid:9559781
Barry AL et al. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). 1998 Antimicrob. Agents Chemother. pmid:9559816
Roblin PM and Hammerschlag MR In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. 1998 Antimicrob. Agents Chemother. pmid:9559818
Hoppe JE and Bryskier A In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). 1998 Antimicrob. Agents Chemother. pmid:9559823
Garcia-Bermejo I et al. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. 1998 Antimicrob. Agents Chemother. pmid:9559831
Mitsuyama T et al. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. 1998 Mol. Cell. Biochem. pmid:9562252
Kieran E et al. Group B streptococcus (GBS) colonisation among expectant Irish mothers. 1998 Jan-Feb Ir Med J pmid:9563251
Salah-Bey K et al. Targeted gene inactivation for the elucidation of deoxysugar biosynthesis in the erythromycin producer Saccharopolyspora erythraea. 1998 Mol. Gen. Genet. pmid:9563840
Jamkhedkar PP et al. Clinico-epidemiologic features of granuloma inguinale in the era of acquired immune deficiency syndrome. 1998 Sex Transm Dis pmid:9564722
Delgado LF et al. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. 1998 Ann. Allergy Asthma Immunol. pmid:9564984
Riley RJ and Howbrook D In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. 1997 J Pharmacol Toxicol Methods pmid:9566442
Andrews PA Interactions with ciprofloxacin and erythromycin leading to aminophylline toxicity. 1998 Nephrol. Dial. Transplant. pmid:9568870
Roark GA Guest clinician: an alternative treatment of RAU (recurrent apthous ulcers). 1996 Miss Dent Assoc J pmid:9571920
Juanqin G et al. Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. 1998 Mar-Apr Pediatr Dermatol pmid:9572705
Elliott RL et al. Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572890
Griesgraber G et al. Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. 1998 J. Med. Chem. pmid:9572891
Stephenson GA et al. Formation of isomorphic desolvates: creating a molecular vacuum. 1998 J Pharm Sci pmid:9572901
Piccolomini R et al. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. 1997 Oral Microbiol. Immunol. pmid:9573812
Higa F et al. Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. 1998 J. Clin. Microbiol. pmid:9574712
Hoppe JE Susceptibility testing of Bordetella pertussis. 1998 J. Clin. Microbiol. pmid:9574735
Bassotti G et al. Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. 1998 Z Gastroenterol pmid:9577904
Ednie LM et al. Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. 1998 J. Antimicrob. Chemother. pmid:9578166
Brett M et al. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis. 1998 J. Antimicrob. Chemother. pmid:9579709
Malizia T et al. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study. 1998 J. Antimicrob. Chemother. pmid:9579710
Bouvier d'Yvoire MJ et al. Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes. 1998 J. Antimicrob. Chemother. pmid:9579715
Bertho G et al. Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. 1998 Int. J. Biol. Macromol. pmid:9585888
Boiron M et al. Erythromycin elicits opposite effects on antro-bulbar and duodenal motility: analysis in diabetics by cineradiography. 1997 Arch. Physiol. Biochem. pmid:9587651
Wieteska M [Legionnaires' diseases]. 1998 Pol. Merkur. Lekarski pmid:9591446
Goldstein EJ et al. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. 1998 Antimicrob. Agents Chemother. pmid:9593139
Spangler SK et al. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. 1998 Antimicrob. Agents Chemother. pmid:9593160
Dodhia H and Miller E Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. 1998 Epidemiol. Infect. pmid:9593483
de Bethune MP and Nierhaus KH Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes. 1978 Eur. J. Biochem. pmid:95947
Hoover J "Antibiotic selection for endodontic infections". 1995 J Gt Houst Dent Soc pmid:9594808
Sakata K et al. [Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation]. 1997 Jpn J Antibiot pmid:9597435
Ieshiro R et al. [Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer]. 1997 Jpn J Antibiot pmid:9597440
Nakada J et al. [Effects of erythromycin and roxithromycin on airway goblet cell secretion]. 1997 Jpn J Antibiot pmid:9597441
Suzuki H et al. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics]. 1997 Jpn J Antibiot pmid:9597442